Venus Concept Inc. to Participate in the Sidoti & Co. Microcap Conference on August 18th

Rhea-AI Summary

Venus Concept, a leader in medical aesthetic technology, announced its participation in the Sidoti & Co. Microcap Conference to be held virtually on August 18-19, 2021. Management will present on August 18 at 8:30 a.m. ET. An audio webcast of the presentation will be available on the Company's investor relations website, with an archive for later replay.

With a diverse product range, including minimally invasive aesthetic devices and hair restoration systems, Venus Concept operates in over 60 countries. The Company favors a subscription-based sales model in North America and direct markets.

TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Sidoti & Co. Microcap Conference, which will be held virtually from August 18th-19th.

Management will present at the conference on Wednesday, August 18th at 8:30 a.m. Eastern Time.

An audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/. An archive of the webcast will be available for replay following the conference.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 20 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

FAQ

What is the date of Venus Concept's presentation at the Sidoti & Co. Microcap Conference?

Venus Concept will present on August 18, 2021, at 8:30 a.m. Eastern Time.

Where can I access the audio webcast of Venus Concept's conference presentation?

The audio webcast will be accessible in the 'Events' section of Venus Concept's investor relations website.

What technologies does Venus Concept offer?

Venus Concept offers a broad range of minimally invasive aesthetic and hair restoration technologies, including devices like Venus Versa and NeoGraft.

How is Venus Concept expanding its market reach?

Venus Concept operates in over 60 countries, focusing on a subscription-based sales strategy in North America and established global markets.

Who are some investors backing Venus Concept?

Venus Concept has backing from leading healthcare growth equity investors such as EW Healthcare Partners and HealthQuest Capital.